Skip to main content

Latest SEC Filings — Page 174

Page 174 · 30 filings scored 7+ · newest 4:30 PM ET · How scores work

Thu, Aug 1330 filings
7BEATHeartBeam, Inc.Strome Entities Dump 1.39M HeartBeam Shares at Steep LossesSchedule 13D/A · Ownership stake▼ Negative7RILYBRC Group Holdings, Inc.BRC Group Amends Oaktree Credit Agreement, Adds $3.1M Fee and New Borrowing Base TermsForm 8-K · Current report● Neutral7CVKDCadrenal Therapeutics, Inc.Cadrenal Reports Q2 Loss, $4.2M Cash Runway to Q1 2027, Launches Partnering ProcessForm 8-K · Current report● Neutral7HKHCHorizon Kinetics Holding CorpHorizon Kinetics Q2 Loss Widens to $18.4M; Declares $0.13 DividendForm 8-K · Current report▼ Negative7YYGHYY Group Holding Ltd.YY Group Buys 95% of Profitable Singapore Distributor for S$4.5MForm 6-K · Current report▲ Positive7RMRegional Management Corp.CEO Lamba Buys $316K of Regional Management StockForm 4 · Insider trade▲ Positive7TSNTyson Foods, Inc.Tyson Foods Restructures Beef Network: Closes Two Plants, Pursues Sale of Pasco FacilityForm 8-K · Current report▼ Negative8VIAVVIAVI SOLUTIONS INC.VIAVI Posts 40% Revenue Growth, $557M Offering, and Major Acquisitions in FY2026Form 10-K · Periodic report● NeutralPro8ULHUniversal Logistics Holdings, Inc.Universal Logistics Q2 Net Income Soars on $45M Property Sale, But Material Weakness PersistsForm 10-Q · Periodic report▼ NegativePro8KEYYKeystone Acquisition Corp.Keystone Acquisition Corp. Flags Going Concern Doubt in First Quarterly ReportForm 10-Q · Periodic report▼ NegativePro7WBDWarner Bros. Discovery, Inc.CEO David Zaslav Files to Sell $21.7M in Warner Bros. Discovery StockForm 144 · Insider trade▼ Negative8ONDSOndas Inc.Ondas Q2 Revenue Soars 1,235% to $83.8M, But Operating Loss Widens to $163MForm 10-Q · Periodic report● NeutralPro7XBPXBP Global Holdings, Inc.XBP Global Posts $16.7M Q2 Loss, Lifts AI Efficiency Goal to $75MForm 8-K · Current report● Neutral7BMMBlue Moon Metals Inc.Blue Moon Metals Posts C$23.5M Q2 Loss, Holds C$159.1M CashForm 6-K · Current report● Neutral7TNONTenon Medical, Inc.Tenon Medical Q2 Revenue Jumps 127% to $1.3M, Gross Margin Hits 64%Form 8-K · Current report▲ Positive7NKTRNektar TherapeuticsNektar's Q2 2026: $1.02B Cash, Phase 3 ZENITH AD Underway, Runway to Q3 2028Form 8-K · Current report▲ Positive8BKSYBlackSky Technology Inc.NYSE Moves to Delist BlackSky Warrants After Trading SuspensionForm 8-K · Current report▼ NegativePro8MAMOMassimo GroupMassimo Group Q2 2026: Net Income Jumps to $1.45M on 48.8% Gross MarginForm 10-Q · Periodic report▲ PositivePro7CAMPCamp4 Therapeutics CorpCamp4's Q2 Loss Widens, but $50M Placement Pushes Cash Runway to 2028Form 10-Q · Periodic report● Neutral8NMGNouveau Monde Graphite Inc.NMG Secures C$427M Financing, Launches Matawinie Mine Construction, and Finalizes Government OfftakeForm 6-K · Current report▲ PositivePro9BZAIBlaize Holdings, Inc.Blaize Flags Going Concern Doubt, Class Action, and Key Supplier ExitForm 10-Q · Periodic report▼ NegativePro7NPWRNet Power Inc.Net Power Shifts to Unabated Gas, Reports $310M CashForm 8-K · Current report▼ Negative8DYNCDynamix CorpDynamix Q2 10-Q: $50M Termination Fee, But Going Concern Doubt LoomsForm 10-Q · Periodic report▼ NegativePro7PEWGrabAGun Digital Holdings Inc.GrabAGun Names Jonathan Terry CFO as Co-Founder Justin Hilty RetiresForm 8-K · Current report● Neutral7JCAPJefferson Capital, Inc.Jefferson Capital Q2 Revenue Beats, But Costs Surge and Net Income Falls 13%Form 10-Q · Periodic report● Neutral9SFRXSeafarer Exploration Corp.Seafarer Exploration Warns Cash Runs Out in Under a Month; Material Weakness DisclosedForm 10-Q · Periodic report▼ NegativePro7GBFHGBank Financial Holdings Inc.GBank Q2 10-Q Reveals Sharp Rise in Non-Performing Assets to $58.2MForm 10-Q · Periodic report▼ Negative8NMAXNewsmax Inc.Newsmax Posts First Quarterly Profit, But Material Weaknesses PersistForm 10-Q · Periodic report▲ PositivePro7ENSCEnsysce Biosciences, Inc.Ensysce's Q2 Loss Widens, but Cy Biopharma Deal Extends Cash Runway to Late 2027Form 8-K · Current report● Neutral7EDSAEdesa Biotech, Inc.Edesa Biotech Reports Wider Q3 Loss, Advances EB06 Phase 2 and Paridiprubart DataForm 8-K · Current report▼ Negative
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.